Pfizer Sues Watson Over Embeda Generic
Pfizer Inc. lodged a patent infringement suit against Watson Pharmaceuticals Inc. and its subsidiaries in Delaware on Thursday in an effort to block it from selling a generic version of painkiller...To view the full article, register now.
Already a subscriber? Click here to view full article